SCHEMBL5348906

SCHEMBL5348906

Cc1cc(Nc2cccc(C(=O)NC(C)(C)CCN)c2)c2ccccc2n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.65
MAPT P10636 2/20 0.54
GUSB P08236 1/20 0.54
HTT P42858 2/20 0.51
TSHR P16473 1/20 0.51
KDM4E B2RXH2 1/20 0.51
DNMT1 P26358 3/20 0.49
DNMT3A Q9Y6K1 3/20 0.49
EHMT1 Q9H9B1 2/20 0.49
DNMT3L Q9UJW3 2/20 0.49
RAD52 P43351 1/20 0.47
OPRK1 P41145 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
TGFBR1 P36897 1/20 0.46
ABCB1 P08183 1/20 0.46
ABCC1 P33527 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5351489 0.94 NPC1 (0.60) NPC1MAPTGUSBHTTTSHR
SCHEMBL4633366 0.85 NPC1 (0.67) NPC1MAPTGUSBHTTTSHR
SCHEMBL5348902 0.83 NPC1 (0.64) NPC1MAPTGUSBHTTTSHR
SCHEMBL5351482 0.81 NPC1 (0.60) NPC1MAPTGUSBHTTTSHR
SCHEMBL13692602 0.80 NPC1 (0.97) NPC1MAPTGUSBHTTTSHR
SCHEMBL4664500 0.79 NPC1 (0.54) NPC1MAPTGUSBHTTTSHR
SCHEMBL4828232 0.79 NPC1 (0.67) NPC1MAPTGUSBHTTTSHR
SCHEMBL5356424 0.78 NPC1 (0.52) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4632922 0.78 NPC1 (0.76) NPC1MAPTGUSBHTTTSHR
SCHEMBL4632753 0.78 NPC1 (0.62) NPC1MAPTGUSBHTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265122-B2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed